Media Contact [email protected] Top Stories August 30, 2021 Y-90 SIRT Cancer Treatment Offers Hope to Liver Cancer Patient Keep Reading May 7, 2021 The Importance of Women’s Health Keep Reading April 26, 2021 Dr. Jeff Geschwind to Serve as Faculty Member at GEST 2021 Liver Cancer Focus Day Keep Reading April 2, 2021 Dr. Jeff Geschwind to be Lecturer at ECIO 2021 Keep Reading 1 2 Next » Media Contact [email protected] NEWS PRESS RELEASES Combining Chemotherapy and Radiation Therapy for Liver Cancer: Is the Solution an Intraarterial Approach? Lipiodol as an Imaging Biomarker of Tumor Response After Conventional Transarterial Chemoembolization: Prospective Clinical Validation in Patients with Primary and Secondary Liver Cancer TACE, Y90, Ablation or Radiation: What, When, and Why? Artificial Intelligence and what it Means for Interventional Oncology Predicting Treatment Response to Intra-arterial Therapies for Hepatocellular Carcinoma with the Use of Supervised Machine Learning-An Artificial Intelligence Concept Science to Practice: Decrypting the Enigma of Ablation-induced Off-Target Effects—Is Network Pathway Analysis the Final Piece of the Puzzle? Read More The Importance of Women’s Health Dr. Jeff Geschwind to Serve as Faculty Member at GEST 2021 Liver Cancer Focus Day Dr. Jeff Geschwind to be Lecturer at ECIO 2021 USA Oncology Centers Opens with Innovative Therapies to Treat Liver Cancer
April 26, 2021 Dr. Jeff Geschwind to Serve as Faculty Member at GEST 2021 Liver Cancer Focus Day Keep Reading
